Several leading private hospital groups in India are reviewing their involvement in government-backed health programmes as financial pressure from these schemes continues to rise. Industry experts say delayed payments, lower package rates and pricing restrictions are reducing profitability for hospitals.
Government schemes such as the Central Government Health Scheme (CGHS) and the Ex-Servicemen Contributory Health Scheme (ECHS) have traditionally contributed a sizeable share of revenue for major hospital chains. However, analysts now expect this share to decline as hospitals shift focus toward privately insured and self-paying patients.
Healthcare consultants estimate that some hospital networks could reduce their exposure to government schemes through selective de-empanelment or by limiting the number of beds allocated under such programmes. Experts believe hospitals are attempting to improve cash flow by prioritising payers with faster settlement cycles.
A few hospital chains have already reported financial stress linked to government healthcare plans. One leading network stated that mandatory discounts on certain cancer medicines significantly affected revenues, while others pointed to delayed reimbursements and capped drug pricing as major concerns.
Some healthcare providers have also restricted the volume of patients admitted under government schemes in selected regions. In a few states, disputes related to payment structures and reimbursement delays have reportedly disrupted hospital operations and treatment cycles.
Despite the challenges, experts believe revised reimbursement rates and faster payment mechanisms could help restore confidence among private hospitals participating in public health programmes. The issue highlights the growing need for a balanced healthcare system that supports both patient affordability and hospital sustainability.
In the coming months, the response of policymakers and healthcare providers will play a crucial role in determining whether private hospitals continue to remain active partners in India’s large-scale public health schemes.